For its promising investigational therapeutic approach to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), BrainStorm Cell Therapeutics is theBuzz of BIO 2020 winnerin the Public Therapeutic Biotech category. The Buzz of BIO contest identifies U.S.
NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029 Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN Key Questions Answered in this Report: What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
Updated January 06, 2020 08:30:20 Since being diagnosed with Hodgkin's lymphoma 18 months ago, Aliona Grytsenko has spent much of her time in and out of hospital.
Recent Comments